CNSP·18978H508·US·equity·Healthcare - Biotechnology-13D/G
CNSP (CNS PHARMACEUTICALS INC) is held by 5 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($55,653), UBS Group AG ($1,742), MAI Capital Management ($8). Net institutional sentiment: Bullish.
See how CNSP's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer